Skip to content

Clinical trials

Terminated Adenocarcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Status: Terminated Clear all

69 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20053
20063
20083
20093
20103
20116
20122
20134
20143
20157
20161
20175
20182
20194
20205
20214
20224
20233
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated69

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris3
Blueprint Medicines Corporation3
Elevation Oncology2
H. Lee Moffitt Cancer Center and Research Institute2
M.D. Anderson Cancer Center2
Mayo Clinic2
National Cancer Institute (NCI)2
Stanford University2
UNICANCER2
Washington University School of Medicine2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma69
Neoplasms20
Carcinoma14
Carcinoma, Non-Small-Cell Lung14
Pancreatic Neoplasms14
Neoplasms by Site9
Stomach Neoplasms9
Carcinoma, Squamous Cell8
Neoplasm Metastasis8
Neoplasms by Histologic Type8

Trials

Showing 26 to 50 of 69. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.